TCMP
CL icon

Thrive Capital Management (Pennsylvania)’s Colgate-Palmolive CL Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.7M Buy
51,230
+4,573
+10% +$400K 0.89% 40
2026
Q1 		$3.98M Sell
46,657
-5,580
-11% -$497K 0.87% 49
2025
Q4 		$4.13M Buy
52,237
+3,551
+7% +$278K 0.92% 39
2025
Q3 		$3.89M Buy
48,686
+13,045
+37% +$1.11M 1% 41
2025
Q2 		$3.24M Buy
35,641
+17,231
+94% +$1.57M 1.01% 38
2025
Q1 		$1.73M Sell
18,410
-7,387
-29% -$661K 1.03% 24
2024
Q4 		$2.35M Buy
25,797
+7,760
+43% +$740K 1.07% 40
2024
Q3 		$1.87M Sell
18,037
-2,321
-11% -$237K 0.88% 40
2024
Q2 		$1.98M Buy
20,358
+7,171
+54% +$662K 0.9% 32
2024
Q1 		$1.19M Buy
+13,187
New +$1.12M 0.63% 34
2023
Q4 		– Sell
-6,238
Closed -$444K – 158
2023
Q3 		$444K Buy
+6,238
New +$466K 0.25% 68

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Thrive Capital Management (Pennsylvania)'s CL Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) increased its Colgate-Palmolive (CL) stake by 9.8% in Q2 2026, buying an estimated $400K and bringing the position to 51,230 shares worth $4.7M. The position accounts for 0.89% of the portfolio, ranked #40.

Thrive Capital Management (Pennsylvania) first reported a position in CL in Q3 2023 and has held it in 11 quarters since. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 51,230 shares of Colgate-Palmolive worth $4.7M as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) bought 4,573 Colgate-Palmolive shares in Q2 2026, an estimated $400K.
  • Colgate-Palmolive made up 0.89% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #40 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Colgate-Palmolive in Q3 2023 and has held it in 11 quarters since.
  • 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.